Dry Age Related Macular Degeneration (AMD) Global Market Report 2025

Global Dry Age Related Macular Degeneration (AMD) Market Report 2025

Dry Age Related Macular Degeneration (AMD) Global Market Report 2025 - By Stages (Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration), By Age Group (Above 75 Years, Above 60 Years, Above 40 Years), By Route Of Administration (Oral, Injectables), By End Users (Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Name: Dry Age Related Macular Degeneration (AMD) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Dry Age Related Macular Degeneration (AMD) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Dry Age Related Macular Degeneration (AMD) Global Market Report 2025

Proud Members Of

What Is Covered Under Dry Age Related Macular Degeneration (AMD) Market

Dry age related macular degeneration (AMD) refers to a progressive eye condition characterized by the gradual deterioration of the macula, the central part of the retina, leading to blurred central vision. They are used for managing and slowing the progression of the disease through treatments like vitamins, nutritional supplements, and emerging pharmaceutical therapies.

The main stages are the dry age related macular degeneration (AMD) of Early Age-Related Macular Degeneration, intermediate age-related macular degeneration, and late age-related macular degeneration. Early age-related macular degeneration (AMD) is the initial stage of a common eye condition that primarily affects older adults, causing changes in the retina, specifically the macula, which is responsible for central vision. It will attack in different age groups, such as above 75 years, above 60 years, and above 40 years. They treated various routes of administration, oral and injectables, and this is using various end users, like hospitals and clinics, diagnostic centers, and academic and research institutes.

How Is The Dry Age Related Macular Degeneration (AMD) Market Segmented?

The dry age related macular degeneration (AMD) market covered in this report is segmented –

1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration

2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years

3) By Route Of Administration: Oral, Injectables

4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes

2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities

3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss

Dry Age Related Macular Degeneration (AMD) Market Size and growth rate 2025 to 2029: Graph

What Is The Dry Age Related Macular Degeneration (AMD) Market Size 2025 And Growth Rate?

The dry age related macular degeneration (AMD) market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to a rising aging population, increased prevalence of chronic diseases, rising awareness of eye health, a growing number of clinical trials focusing on dry AMD, and growing demand for minimally invasive treatments.

What Is The Dry Age Related Macular Degeneration (AMD) Market Growth Forecast?

The dry age related macular degeneration (AMD) market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging novel therapies, increasing healthcare expenditure, rising utilization of laser photocoagulation therapy, advancements in genetic research, and a growing focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, rising adoption of teleophthalmology, technologically advanced treatments, product approvals, and new product launches.

Book your 30 minutes free consultation with our research experts

What Is Driving The Dry Age Related Macular Degeneration (AMD) Market: Rising Geriatric Population To Drive The Market Growth

The growing geriatric population is expected to propel the growth of the dry age related macular degeneration (AMD) market going forward. The geriatric population refers to older adults, typically defined as individuals aged 65 years and older. The increasing geriatric population is due to several reasons, such as advancements in medical technology, better management of chronic diseases, increased life expectancy, and improved geriatric care. Dry age-related macular degeneration (AMD) helps the geriatric population by providing targeted treatments and management options that aim to slow disease progression, preserve vision, and improve the quality of life for older individuals affected by this condition. For instance, in June 2024, according to reports published by the National Council on Aging, a US-based organization, in 2022, there were approximately 57.8 million adults aged 65 and older, representing 17.3% of the total U.S. population. This marked an increase from 16.9% in 2021. Therefore, the growing geriatric population will drive the growth of the dry age-related macular degeneration (AMD) market.

Who Are The Major Players In The Global Dry Age Related Macular Degeneration (AMD) Market?

Major companies operating in the dry age related macular degeneration (AMD) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.

What Are The Key Trends Of The Global Dry Age Related Macular Degeneration (AMD) Market: Advancements In Dry AMD Treatment Lumithera's Valeda Light Delivery System

Major companies operating in the dry age related macular degeneration (AMD) market are focused on developing new advanced technologies and treatments, such as light delivery systems, to target and activate retinal cells, potentially slowing disease progression. Light delivery systems refer to technologies designed to transmit light for therapeutic applications, particularly in medical treatments. For instance, in January 2024, LumiThera Inc., a US-based medical device company, launched photobiomodulation (PBM) for dry age-related macular degeneration (AMD) with the Valeda Light Delivery System. This is the first FDA-authorized therapy designed to address vision loss in patients suffering from dry AMD, a condition that currently has limited treatment options. LumiThera initiated the EUROLIGHT registry study to gather long-term data on the outcomes of patients treated with the Valeda system. The Valeda system utilizes a multi-wavelength light delivery method that employs three specific wavelengths (590 nm, 660 nm, and 850 nm). This non-invasive treatment can be administered through either an open or closed eyelid and typically requires nine sessions over three to four weeks.

What Are Latest Mergers And Acquisitions In The Dry Age Related Macular Degeneration (AMD) Market: Astellas Pharma Acquires IVERIC Bio To Enhance Ophthalmology R&D

In May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired IVERIC Bio Inc. for $5.9 billion. Through this acquisition, Astellas Pharma Inc. aims to expand its presence in the ophthalmology market and accelerate the development of novel treatments in the field of ophthalmology and treating retinal diseases and improve outcomes for patients suffering from these conditions worldwide. IVERIC Bio Inc. is a US-based biotech company that develops age-related macular degeneration drugs and products for treatment.

What Is The Regional Outlook For The Global Dry Age Related Macular Degeneration (AMD) Market?

North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dry age related macular degeneration (AMD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Dry Age Related Macular Degeneration (AMD) Market?

The dry age related macular degeneration (AMD) market consists of sales of syfovre, zimura, visudyne, and alk-001. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Dry Age Related Macular Degeneration (AMD) Industry?

The dry age related macular degeneration (AMD) market research report is one of a series of new reports from The Business Research Company that provides dry age related macular degeneration (AMD) market statistics, including dry age related macular degeneration (AMD) industry global market size, regional shares, competitors with a dry age related macular degeneration (AMD) market share, detailed dry age related macular degeneration (AMD) market segments, market trends and opportunities, and any further data you may need to thrive in the dry age related macular degeneration (AMD) industry. This dry age related macular degeneration (AMD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dry Age Related Macular Degeneration AMD Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.90 billion
Revenue Forecast In 2034	$6.86 billion
Growth Rate	CAGR of 8.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The dry age related macular degeneration (AMD) market covered in this report is segmented – 1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration 2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years 3) By Route Of Administration: Oral, Injectables 4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes Subsegments: 1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes 2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities 3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Dry Age Related Macular Degeneration (AMD) Market Characteristics

3. Dry Age Related Macular Degeneration (AMD) Market Trends And Strategies

4. Dry Age Related Macular Degeneration (AMD) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dry Age Related Macular Degeneration (AMD) Growth Analysis And Strategic Analysis Framework

5.1. Global Dry Age Related Macular Degeneration (AMD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Dry Age Related Macular Degeneration (AMD) Market Growth Rate Analysis

5.4. Global Dry Age Related Macular Degeneration (AMD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Dry Age Related Macular Degeneration (AMD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Dry Age Related Macular Degeneration (AMD) Total Addressable Market (TAM)

6. Dry Age Related Macular Degeneration (AMD) Market Segmentation

6.1. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early Age-Related Macular Degeneration

Intermediate Age-Related Macular Degeneration

Late Age-Related Macular Degeneration

6.2. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Above 75 Years

Above 60 Years

Above 40 Years

6.3. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectables

6.4. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Centers

Academic And Research Institutes

6.5. Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Early Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drusen Accumulation

Retinal Pigment Epithelium Changes

6.6. Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Intermediate Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Larger Drusen Deposits

Increased Pigmentary Abnormalities

6.7. Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Late Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Geographic Atrophy

Central Vision Loss

7. Dry Age Related Macular Degeneration (AMD) Market Regional And Country Analysis

7.1. Global Dry Age Related Macular Degeneration (AMD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Dry Age Related Macular Degeneration (AMD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market

8.1. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dry Age Related Macular Degeneration (AMD) Market

9.1. China Dry Age Related Macular Degeneration (AMD) Market Overview

9.2. China Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dry Age Related Macular Degeneration (AMD) Market

10.1. India Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dry Age Related Macular Degeneration (AMD) Market

11.1. Japan Dry Age Related Macular Degeneration (AMD) Market Overview

11.2. Japan Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dry Age Related Macular Degeneration (AMD) Market

12.1. Australia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dry Age Related Macular Degeneration (AMD) Market

13.1. Indonesia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dry Age Related Macular Degeneration (AMD) Market

14.1. South Korea Dry Age Related Macular Degeneration (AMD) Market Overview

14.2. South Korea Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dry Age Related Macular Degeneration (AMD) Market

15.1. Western Europe Dry Age Related Macular Degeneration (AMD) Market Overview

15.2. Western Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dry Age Related Macular Degeneration (AMD) Market

16.1. UK Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dry Age Related Macular Degeneration (AMD) Market

17.1. Germany Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dry Age Related Macular Degeneration (AMD) Market

18.1. France Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dry Age Related Macular Degeneration (AMD) Market

19.1. Italy Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dry Age Related Macular Degeneration (AMD) Market

20.1. Spain Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market

21.1. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market Overview

21.2. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dry Age Related Macular Degeneration (AMD) Market

22.1. Russia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dry Age Related Macular Degeneration (AMD) Market

23.1. North America Dry Age Related Macular Degeneration (AMD) Market Overview

23.2. North America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dry Age Related Macular Degeneration (AMD) Market

24.1. USA Dry Age Related Macular Degeneration (AMD) Market Overview

24.2. USA Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dry Age Related Macular Degeneration (AMD) Market

25.1. Canada Dry Age Related Macular Degeneration (AMD) Market Overview

25.2. Canada Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dry Age Related Macular Degeneration (AMD) Market

26.1. South America Dry Age Related Macular Degeneration (AMD) Market Overview

26.2. South America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dry Age Related Macular Degeneration (AMD) Market

27.1. Brazil Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dry Age Related Macular Degeneration (AMD) Market

28.1. Middle East Dry Age Related Macular Degeneration (AMD) Market Overview

28.2. Middle East Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dry Age Related Macular Degeneration (AMD) Market

29.1. Africa Dry Age Related Macular Degeneration (AMD) Market Overview

29.2. Africa Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dry Age Related Macular Degeneration (AMD) Market Competitive Landscape And Company Profiles

30.1. Dry Age Related Macular Degeneration (AMD) Market Competitive Landscape

30.2. Dry Age Related Macular Degeneration (AMD) Market Company Profiles

30.2.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Dry Age Related Macular Degeneration (AMD) Market Other Major And Innovative Companies

31.1. Astellas Pharma Inc.

31.2. Bausch Health Companies Inc.

31.3. Lupin Ltd.

31.4. Santen Pharmaceuticals Inc.

31.5. Biocon Ltd.

31.6. Alimera Sciences Inc.

31.7. Apellis Pharmaceuticals Inc.

31.8. Belite Bio Inc.

31.9. Axol Bioscience Ltd.

31.10. Alkeus Pharmaceuticals Inc.

31.11. Kubota Holdings Co.

31.12. Ribomic Inc.

31.13. Eyestem Research Pvt. Ltd.

31.14. LumiThera Inc.

31.15. Adverum Biotechnologies Inc.

32. Global Dry Age Related Macular Degeneration (AMD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dry Age Related Macular Degeneration (AMD) Market

34. Recent Developments In The Dry Age Related Macular Degeneration (AMD) Market

35. Dry Age Related Macular Degeneration (AMD) Market High Potential Countries, Segments and Strategies

35.1 Dry Age Related Macular Degeneration (AMD) Market In 2029 - Countries Offering Most New Opportunities

35.2 Dry Age Related Macular Degeneration (AMD) Market In 2029 - Segments Offering Most New Opportunities

35.3 Dry Age Related Macular Degeneration (AMD) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Early Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Intermediate Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Late Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: F Hoffmann-La Roche Ltd. Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: Bayer AG Financial Performance

Table 81: Amgen Inc. Financial Performance

Table 82: Biogen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Early Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Intermediate Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Late Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Admininstration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: F Hoffmann-La Roche Ltd. Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: Bayer AG Financial Performance

Figure 81: Amgen Inc. Financial Performance

Figure 82: Biogen Inc. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Macular Degeneration Treatment Global Market Report 2025 – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By End User (Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals), By Route of Administration (Oral, Injectable, Other Route of Administration), By Types (Wet Macular Degeneration, Dry Macular Degeneration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Age-Related Macular Degeneration Global Market Report 2025 – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Products), By Route Of Administration (Intravenous, Intravitreal), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cartilage Degeneration Global Market Report 2025- By Procedure (Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell-Based Cartilage Resurfacing, Autologous Chondrocyte Implantation, Other Procedures), By Application (Knee, Hip, Other Applications), By End User (Hospitals And Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes)- Market Size, Trends, And Global Forecast 2025-2034

View Report

Macular Edema and Macular Degeneration Global Market Report 2025 – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration), By End User (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vitreoretinal Surgery Devices Global Market Report 2025 – By Product (Photocoagulation Lasers, Illumination Devices, Vitrectomy Machines, Vitrectomy Probes, Vitreoretinal Packs, Other Products), By Surgery (Anterior Vitreoretinal Surgery, Posterior Vitreoretinal Surgery), By Application (Diabetic Vitreous Hemorrhage, Retinal Detachment, Macular Hole, Other Applications), By End-Users (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Retinal Biologics Global Market Report 2025 – By Drug Class (Vascular Endothelial Growth Factor (VEGF)-A Antagonist, Tumor Necrosis Factor (TNF)-A Inhibitor), By Indication (Macular Degeneration, Diabetic Retinopathy, Uveitis, Diabetic Macular Edema, Other Indications), By Distribution Channel (Hospitals, Pharmacies, Specialty Clinics, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Retinal Disorder Treatment Global Market Report 2025 – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Retinal Vein Occlusion Global Market Report 2025 – By Type (Branch Retinal Artery Occlusion, Central Retinal Vein Occlusion), By Condition (Non-Ischemic, Ischemic), By Diagnosis (Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography), By Treatment (Antivascular Endothelial Growth Factor, Corticosteroid Drugs, Laser Retinal Photocoagulation), By End User (Hospitals And Clinics, Research And Academics Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Dry Age Related Macular Degeneration (AMD) market?

How will the Dry Age Related Macular Degeneration (AMD) market drivers and restraints affect the market dynamics? What forces will shape the Dry Age Related Macular Degeneration (AMD) industry going forward?

The Dry Age Related Macular Degeneration (AMD) market major growth driver - Rising Geriatric Population To Drive The Market Growth. For further insights on the Dry Age Related Macular Degeneration (AMD) market, request a sample here

What is the forecast market size or the forecast market value of the Dry Age Related Macular Degeneration (AMD) market?

The Dry Age Related Macular Degeneration (AMD) market size has grown strongly in recent years. The dry age related macular degeneration (AMD) market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to a rising aging population, increased prevalence of chronic diseases, rising awareness of eye health, a growing number of clinical trials focusing on dry AMD, and growing demand for minimally invasive treatments. The dry age related macular degeneration (AMD) market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging novel therapies, increasing healthcare expenditure, rising utilization of laser photocoagulation therapy, advancements in genetic research, and a growing focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, rising adoption of teleophthalmology, technologically advanced treatments, product approvals, and new product launches. For further insights on the Dry Age Related Macular Degeneration (AMD) market, request a sample here

How is the Dry Age Related Macular Degeneration (AMD) market segmented?

The dry age related macular degeneration (AMD) market covered in this report is segmented –
1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration
2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years
3) By Route Of Administration: Oral, Injectables
4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:
1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes
2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities
3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss For further insights on the Dry Age Related Macular Degeneration (AMD) market, request a sample here

Which region has the largest share of the Dry Age Related Macular Degeneration (AMD) market? What are the other regions covered in the report?

Who are the major players in the Dry Age Related Macular Degeneration (AMD) market?

What are the key trends in the Dry Age Related Macular Degeneration (AMD) market?

Major trends in the Dry Age Related Macular Degeneration (AMD) market include Advancements In Dry AMD Treatment Lumithera's Valeda Light Delivery System. For further insights on the Dry Age Related Macular Degeneration (AMD) market, request a sample here.

What are the major opportunities in the Dry Age Related Macular Degeneration (AMD) market? What are the strategies for the Dry Age Related Macular Degeneration (AMD) market?

For detailed insights on the major opportunities and strategies in the Dry Age Related Macular Degeneration (AMD) market, request a sample here.

How does the Dry Age Related Macular Degeneration (AMD) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Dry Age Related Macular Degeneration (AMD) market growth and SWOT analysis of the Dry Age Related Macular Degeneration (AMD) industry, request a sample here.

For detailed insights on Dry Age Related Macular Degeneration (AMD)'s relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Dry Age Related Macular Degeneration (AMD) industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Dry Age Related Macular Degeneration (AMD) industry,

What are the key dynamics influencing the Dry Age Related Macular Degeneration (AMD) market growth? SWOT analysis of the Dry Age Related Macular Degeneration (AMD) market. request a sample here.